HIGHLIGHTS
- who: Puneeth Iyengar et al. from the Department of Radiation Oncology, University of Texas Southwestern, Dallas, USA have published the research: A phase I study with Satraplatin and simultaneous chest radiation for non-small cell lung cancer, in the Journal: (JOURNAL)
- what: Diation (TRT) for patients with stage III non-small cell lung cancer (NSCLC).
SUMMARY
Satraplatin has been given in combination therapy for lung cancer to utilize its radio-sensitizing properties. The optimal dose of satra-platin given concurrently with radiation therapy for locally advanced non-small cell lung cancer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.